Quality of Vision in Eyes with Chronic Dacryocystitis After Endoscopic Dacryocystorhinostomy

Abstract

Purpose

To assess the quality of vision (QOV) of patients with chronic dacryocystitis and explore the impact of endoscopic dacryocystorhinostomy (En-DCR) on patients’ QOV, with the aim of increasing clinicians’ attention to the potential QOV changes in patients with chronic dacryocystitis.

Patients and Methods

Chronic dacryocystitis patients who attended the Department of Oculoplastics, Zhongshan Ophthalmic Center, Sun Yat-sen University from January 2022 to June 2022 and had En-DCR were included. The QOV was evaluated preoperatively and postoperatively using the Quick-contrast sensitivity function test (qCSF) and the OPD ScanIII comprehensive visual quality analyser, and the contrast sensitivity function (CSF), higher-order aberrations (HOAs), and modulation transfer function (MTF) data were recorded.

Results

Thirty-eight patients with chronic dacryocystitis were included. QOV analysis of those with monocular chronic dacryocystitis revealed that HOAs were significantly higher in affected eyes than in contralateral eyes (P < 0.05), and CSF and MTF were significantly lower in affected eyes than in contralateral eyes (P < 0.05). One month after En-DCR, patients’ HOAs, CSF, and MTF were significantly improved (P < 0.05), and there was no statistically significant difference in the effect of intraoperative combined silicone intubation versus no intubation on QOV (P > 0.05).

Conclusion

Chronic dacryocystitis can significantly affect the QOV of patients. Successful En-DCR significantly improves the CSF, HOAs and MTF, which can effectively improve the QOV.

Keywords:

• chronic dacryocystitis
• contrast sensitivity function
• higher-order aberrations
• modulation transfer function
• endoscopic dacryocystorhinostomy

Data Sharing Statement

The data used for the analysis are available from the corresponding author upon reasonable request.

Ethical Approval

The study followed the principles of the Declaration of Helsinki and was approved by the Ethics Committee of Zhongshan Ophthalmic Center, Sun Yat-sen University (Approved ID: 2021KYPJ100).

Author Contributions

All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published. All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas, with Ziwei Meng, Rongxin Chen, Shujuan Cao and Xuanwei Liang served as the main leaders in the process of drafting, revising or critically reviewing the article. All named authors gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

Disclosure

The authors report no conflicts of interest in this work.

Additional information

Funding

This study was partly supported by Zhongshan Ophthalmic Center Clinical Specialty Construction Project (No. 3030901010071), Natural Science Foundation of Guangdong Province (No. 2021A1515012043), Xinjiang Uygur Autonomous Region Innovation Environment (Talents, Bases) Special Project (Tianshan Youth Project) Funding Project (No. 2019Q145), and the Pearl River Scholar Tianshan Talent Cooperation’s Expert Studio Innovation Team (No. KDYY202018).